IGF2BP3 and neoplasm: Vikesaa compared the phenotypes of IGF2BP3‐silenced cells and nonsilenced cells in vitro and observed that tumour cells expressing IGF2BP3 showed significant cell elongation and motility phenotypes, such as increased adhesion between cells.6